Group items tagged

Prevalence of cancer is on the rise throughout the world. Advanced therapeutics are being developed by pharmaceutical companies to address the growing burden of cancer. The time and costs associated with oncology drug development are also increasing; hence the key companies are collaborating with other pharmaceutical companies to reduce these costs.

Chronic lymphocytic leukemia is a cancerous disease in which cancer cells begin to multiply in the lymph cells. CLL is aggressive cancer that invades the lymphatic system and attacks healthy cells of the immune system. It typically affects the lymph nodes and T cells, although it can also affect any other cells in the human body. The combination of chemotherapy is aimed at destroying cancer cells while at the same time allowing the body's immune system to restore the damaged cells. This allows for a more rapid response to the infection and better overall outcomes. As a result of this combination, chemotherapy is often used to treat several types of cancer at one time. It has been very successful in achieving results against most types of cancer. The targeted drugs are given to make the cancer cells unable to multiply and thus stop their growth. Increasing prevalence of leukemia is expected to drive growth of the global chronic lymphocytic leukemia therapeutics market during the forecast period. According to the American Society of Clinical Oncology (ASCO), chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults aged 19 years and above with 37% of cases. According to the same source, around 21,040 new cases and 4,060 deaths are expected to occur in 2020 due to CLL in the U.S. Furthermore, according to the Leukemia & Lymphoma Society (LLC), in 2020, around 60,530 people are expected to be diagnosed with leukemia in the U.S. Such a high prevalence of CLL and leukemia has increased the demand for necessary therapeutics such as chemotherapy. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/chronic-lymphocytic-leukemia.html

High prevalence of gastric cancer is expected to propel growth of the gastric cancer therapeutics market. For instance, according to The American Cancer Society, the U.S. is estimated to record about 26,560 cases of stomach cancer and about 11,180 people will die from this type of cancer in 2021. Moreover, R&D in oral chemotherapy for the treatment of gastric cancer is also expected to aid in growth of the market. For instance, in January 2021, Ascelia Pharma AB announced the clinical development plan for Oncoral, with which the company has the opportunity to develop a novel oral chemotherapy for the treatment of gastric cancer. Risk factors for gastric cancer may include smoking and a diet of highly processed or salty foods. Thus, high number of smokers is expected to offer lucrative growth opportunities for players in the gastric cancer therapeutics market. For instance, according to the World Health Organization's, May 2020 Update, tobacco leads to over 8 million deaths each year worldwide and over 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-gastric-cancer-and.html

"Dental Caries - Pipeline Review, H1 2013"provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Dental Caries, complete with latest updates, and special features on late-stage and discontinued projects.

Endoscopy Devices: Making Pathways in Diagnostics and Therapeutics.Several diseases that require the use of endoscopy devices for diagnostics, as well as therapeutics, have been on the rise across various countries. The clinically unmet demands of such diseases in developing nations have resulted in a flourishing growth for the global endoscopy devices market.

Any drug or pesticide that is made or extracted from parts of plants is referred to as botanical extracts. These extracts are 100% all-natural. They are usually extracted from plant sources; these include herbs and flowers, whose healing properties have been known since the earliest times. Today, they are used by alternative medicine practitioners to treat a wide range of medical conditions. Botanical extracts from these plants can be very effective as they help reduce appetite. The main reason is because they contain fatty acids that act as a signal to the brain telling it that the body has enough energy to burn fat but are not getting sufficient calories. Botanical extracts are concentrated plant materials providing therapeutic properties, which have been extracted through a variety of methods. When taken in conjunction with a healthy diet and regular exercise, these extracts may help lose weight. This is due to the fact that they cause the brain to think that the body is full and can now use some of its resources for other purposes, resulting in a decreased desire for food. When combined with certain other natural ingredients, extracts from these plants can also help to naturally boost metabolism so that it burns fat more efficiently. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/03/botanical-extracts-obtained-from-plants.html

The growing incidence of viral conjunctivitis cases is driving the growth of the viral conjunctivitis drugs market. According to National Center for Biotechnology: 2017, adenovirus is the most common cause of viral conjunctivitis and up to 70% of cases of acute conjunctivitis are viral. The number of individuals affected by viral conjunctivitis is estimated to be as high as 15 to 20 million per year in the U.S. Additionally, a rising number of research and development activities for enhancing the effectiveness of viral conjunctivitis drugs is again projected to accelerate the growth of the market. For instance, in 2019, iVIEW Therapeutics Inc., a clinical-stage ophthalmology drug development company, announced the dosing of the first patient in Phase II clinical trial. iVIEW Therapeutics Inc. is testing the safety and efficacy of the IVIEW-1201 in patients (age ≥15 years) for the treatment of acute adenoviral conjunctivitis. In 2018, Starpharma Holdings Limited, a company headquartered in Australia, received a patent for SPL7013 ophthalmic drops for viral conjunctivitis from the U.S. Patent and Trademark Office. The patent has been granted to the company due to its broad claims for treating and preventing microbial infections of the eye, including adenoviral conjunctivitis, bacterial conjunctivitis, and other eye infections. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/starpharma-holdings-limited-received.html

Europe constitutes the highest market share in the global cystic fibrosis therapeutics market in 2018, followed by North America owing to the increase in incidence of cystic fibrosis. Moreover, increase in governmental support for innovation and rise in funding of projects for R&D of various cystic fibrosis drugs further fuel the market growth in this region.

Thigh Support Applications Mild support to quadriceps and hamstrings. Relieves inflammation and stiffness. Firm compression and therapeutic warmth. Psychological support to geriatric patients. Sports injury, sprains and strains. Post-surgical rehabilitation. Burn care. Thigh Support Features Strong Compression. Four way stretch. Dermophillic. Durable. Breathable and comfortable. Thigh Support Measurements Measure circumference around mid thigh - approximately 6 inches above knee. Size Chart - Size Inches CM Small 14.8 to 17.2 37 to 43 Medium 17.2 to 19.6 43 to 49 Large 19.6 to 22.0 49 to 55

"Dental Pain - Pipeline Review, H1 2013" information on the therapeutic development for Dental Pain, complete with latest updates, and special features on late-stage and discontinued projects.

Tynor Anklet (Pair) Anklets are tubular supports widely used in orthopedic practice to provide mild compression, warmth & support to the ankle joint, to allay pain and inflammation generally associated with old age, arthritis, sports etc. Four way stretch Two layered fabric Hypoallergenic Uniform compression Simple pull on application Tynor Anklet (Pair) Features Bilayered , cotton on the inside Dermophillic interpahse with the skin Better sweat absorption Better comfort Better patient compliance. No allergies or rash Bilayered, nylon on the outside Ensures long life Excellent aesthetics Color fastness. Two layers enclose air space retains body heat effectively Provides therapeutic warmth and assuring support to the knee. Four-way stretchable seamless tubular fabric Effective compression Enhanced comfort. No vaso constriction. Adjusts compression even on uneven diameters Simple pull on application improves patient compliance. Tynor Anklet (Pair) Measurements Measure circumference approx 2 inches above the ankle joint. Size Chart - Size Inches CM Small 7.2-8.4 18-21 Medium 8.4-9.6 21-24 Large 9.6-10.8 24-27 XL 10.8-12 27-30

Tynor Knee Cap Pair Knee Caps are tubular supports widely used in orthopaedic practice to provide mild compression warmth & support to the limbs and joints, to allay pain and inflammation, generally associated with old age, arthritis, sports injury etc. Hypoallergenic Four way stretch Uniform compression Simple pull on application Tynor Knee Cap (Pair) Features Bilayered , cotton on the inside Dermophillic interpahse with the skin Better sweat absorption Better comfort Better patient compliance. No allergies or rash Bilayered, nylon on the outside Ensures long life Excellent aesthetics Color fastness. Two layers enclose air space retains body heat effectively Provides therapeutic warmth and assuring support to the knee. Four-way stretchable seamless tubular fabric Effective compression Enhanced comfort. No vaso constriction. Adjusts compression even on uneven diameters

Tynor Compression Stocking Below Knee Compression Stockings provide controlled compression to the legs to squeeze away abnormal back flow of blood into the superficial veins that lie just beneath the surface of the skin from the perforating veins. It is used in all forms of venous disease including blood pools or congests in legs. Severe varicose veins and discoloration to sores, ulcers and potentially life-threatening blood clots. Light weight. Four way stretch. Freely breathable. Soft and comfortable. Tynor Compression Stocking Below Knee Features Made from soft nylon yarn and spandex Strong and durable. Dermophillic. Optimal compression. Excellent aesthetics. Excellent Color fastness. Four-way stretchability Offers optimal compression. Snug fitting. Double layered Retains body heat effectively. Provides therapeutic warmth. Quicker healing. Strong and durable. Tapered shape and Controlled compression Uniform compression even on uneven limb surface. Offers graded compression high to low from toe upwards. Effective blood evacuation. Open toe design Reduces wear and tear. Easy to wear. Compatible to toe rings or other jewelry items. Tynor Compression Stocking Below Knee Measurements

The Human Microbiome refers to the group of microorganisms that reside on skin layers, and in saliva, conjunctiva, oral mucosa and the gastrointestinal tract (GIT). It includes bacteria, archaea and fungi. Despite being parasites, these microorganisms perform tasks which are beneficial for the human host in maintaining health.

Durable Medical Equipment Billing is somewhat unique if we compare it with other specialty billing. Basically, Durable Medical Equipment (DME) gives therapeutic benefits to patients experiencing certain healing conditions and/or some diseases.

Outline Value Based Healthcare System - How it is seen today Healthcare Challenge & IoT as a Solution IoT - Big Data Structure Recent Trends in IoT Big Data Analytics Challenges & Our Future In-depth Knowledge of What causes the most premature death? Distribution of Disease burden from 1990 - 2020 Challenges in Healthcare Future Healthcare IoT Machine Talking to Machine Prediction of IoT Usage About PEPGRA HEALTHCARE, A leading healthcare communication firm with years of excellence serving clients with a dedicated team of Medical, Regulatory and Scientific writers specialized in all therapeutic areas. Contact us at : UK: +44-1143520021 US/Canada: +1-972-502-9262 India: +91-8754446690 info@pepgra.com www.pepgra.com

Apheresis is an innovative medical procedure where the blood is extracted from the patient's body and then desired blood components (such as platelets, plasma, white cells, and red cells) are separated based on their weight and size. Depending on the cause of apheresis, one of these components is isolated and collected, while the other components are returned to the body. Apheresis is a blood purification procedure performed for blood donation component or for the treatment of disease. It is performed for various diseases such as hematological, autoimmune, renal, cardiovascular, neurological, and more. In apheresis procedure, the centrifuge therapeutic devices are used to separate desired blood components from the donor's blood. These blood components are separated based on their characteristics such as affinity for substance, molecular weight, and size among other factors. The emergence of COVID-19 is expected to propel the growth of the apheresis market. For instance, according to the Food and Drug Control Administration (Gujarat, India), there were 13 plasma apheresis units in the state before the pandemic, now the number has jumped to 28 to meet the requirement of plasma used in convalescent plasma therapy. Moreover, worldwide, as of 9:47am CET, 13 January 2021, there have been 90,054,813 confirmed cases of COVID-19, including 1,945,610 deaths, according to the World Health Organization (WHO). Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/emergence-of-covid-19-is-expected-to.html

Alkaline proteases are a type of enzyme that is active from neutral to pH range. An enzyme is any living thing that can be defined as a chemical reaction that changes something else, usually making a change in its shape or composition at some point during the catalytic reaction. The catalytic reaction may be a kinetic one - that is, it changes something because of the energy produced - or it may be a metabolic one - that is, it changes something because of the energy available for the catalytic reaction. Basically, an enzyme performs a number of functions: breaking down complex molecules into simple substances, assembling amino acids into peptide chains, playing a role in metabolism, and so on. The expanding biotechnology industry due to technological advancement is driving the growth of alkaline proteases market. The rise in the investment in research &development activities is again expected to augment market growth. High demand for proteases from the soaps & detergents industry is also projected to foster the market growth of alkaline proteases. Growing hygiene awareness and increasing demand for the food industry for the preparation of food products is also projected to propel the market growth. Furthermore, the growing demand for environmentally friendly products across emerging economies and increasing use of proteases as therapeutic agents is further projected to augment the growth of alkaline proteases market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/advancement-in-biotechnology-sector-has.html